Legend Biotech Corp Adr (LEGN)

Legend Biotech Corp Stock (LEGN) dropped by 5.37% from $60.50 to $57.25 in the trading on Tuesday November 21, 2023. The reasons why LEGN stock down today include:

• Mixed third-quarter results: Legend Bio reported third quarter EPS of $-0.17, $0.14 better than the analyst estimate of $-0.31. Revenue for the quarter came in at $96.01M versus the consensus estimate of $97.42M.
• New Competitors: Arcellx’s CART-ddBCMA emerged as a strong competitor in the CAR-T MM market, Arcellx’s CART-ddBCMA has shown promising efficacy and safety data, positioning it as a viable alternative to Carvykti​​.